Drug Type CAR-T |
Synonyms CD138 CART cell therapy Yake Biotechnology |
Target |
Action inhibitors |
Mechanism CD138 inhibitors(Syndecan-1 inhibitors), Gene transference(Gene transference), T lymphocyte replacements |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Multiple Myeloma | Preclinical | China | 11 Dec 2017 |